Tumor necrosis factor-α promotes phosphoinositide 3-kinase enhancer A and AMP-activated protein kinase interaction to suppress lipid oxidation in skeletal muscle

Diabetes

Volumn 66, Issue 7, 2017, Pages 1858-1870

  Tse, Margaret Chui Ling ^a   Herlea Pana, Oana ^b   Brobst, Daniel ^b   Yang, Xiuying ^b,c   Wood, John ^b   Hu, Xiang ^b   Liu, Zhixue ^b   Lee, Chi Wai ^a   Zaw, Aung Moe ^a   Chow, Billy K C ^a   Ye, Keqiang ^d   Chan, Chi Bun ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c INSTITUTE OF MATERIA MEDICA   (China)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INFLIXIMAB; LIPID; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE 3 KINASE ENHANCER A; RECOMBINANT TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ADENOSINE PHOSPHATE; ANTIRHEUMATIC AGENT; GUANOSINE TRIPHOSPHATASE; NERVE PROTEIN; PIKE PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; DIETARY INTAKE; ENERGY YIELD; FEMALE; GENE OVEREXPRESSION; HYPERLIPIDEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; LIPID DIET; LIPID OXIDATION; LIPID STORAGE; MITOCHONDRIAL RESPIRATION; MOUSE; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SKELETAL MUSCLE; SKELETAL MYOBLAST; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BODY COMPOSITION; DRUG EFFECTS; GENETICS; GLUCOSE CLAMP TECHNIQUE; IMMUNOPRECIPITATION; KNOCKOUT MOUSE; LIPID METABOLISM; LOCOMOTION; METABOLISM; MUSCLE MITOCHONDRION; OBESITY; OXIDATION REDUCTION REACTION; SKELETAL MUSCLE CELL; WESTERN BLOTTING;

ADENOSINE MONOPHOSPHATE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTIRHEUMATIC AGENTS; BLOTTING, WESTERN; BODY COMPOSITION; DIET, HIGH-FAT; FEMALE; GLUCOSE CLAMP TECHNIQUE; GTP PHOSPHOHYDROLASES; IMMUNOPRECIPITATION; INFLIXIMAB; INSULIN RESISTANCE; LIPID METABOLISM; LOCOMOTION; MICE; MICE, KNOCKOUT; MITOCHONDRIA, MUSCLE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; NERVE TISSUE PROTEINS; OBESITY; OXIDATION-REDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85021183372     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db16-0270     Document Type: Article

References (48)

1. Aggarwal BB, Gupta SC, Kim JH. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood 2012;119: 651-665
2. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-Alpha: Direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91
3. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112: 1796-1808
4. Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-Jun NH(2)-Terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 2000;275: 9047-9054
5. Lang CH, Dobrescu C, Bagby GJ. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 1992;130: 43-52
6. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci U S A 1994;91: 4854-4858
7. Emanuelli B, Peraldi P, Filloux C, et al. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-Alpha in the adipose tissue of obese mice. J Biol Chem 2001;276: 47944-47949
8. Fernández-Veledo S, Nieto-Vazquez I, Rondinone CM, Lorenzo M. Liver X receptor agonists ameliorate TNFαlpha-induced insulin resistance in murine brown adipocytes by downregulating protein tyrosine phosphatase-1B gene expression. Diabetologia 2006;49: 3038-3048
9. Plomgaard P, Fischer CP, Ibfelt T, Pedersen BK, van Hall G. Tumor necrosis factor-Alpha modulates human in vivo lipolysis. J Clin Endocrinol Metab 2008;93: 543-549
10. Kralisch S, Klein J, Lossner U, et al. Isoproterenol, TNFαlpha, and insulin downregulate adipose triglyceride lipase in 3T3-L1 adipocytes. Mol Cell Endocrinol 2005;240: 43-49
11. Sumida M, Sekiya K, Okuda H, Tanaka Y, Shiosaka T. Inhibitory effect of tumor necrosis factor on gene expression of hormone sensitive lipase in 3T3-L1 adipocytes. J Biochem 1990;107: 1-2
12. Steinberg GR, Michell BJ, van Denderen BJ, et al. Tumor necrosis factor alphainduced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab 2006;4: 465-474
13. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA. The Ca2+/calmodulin-dependent protein kinase kinases are AMP-Activated protein kinase kinases. J Biol Chem 2005;280: 29060-29066
14. Woods A, Johnstone SR, Dickerson K, et al. LKB1 is the upstream kinase in the AMP-Activated protein kinase cascade. Curr Biol 2003;13: 2004-2008
15. Thomson DM, Winder WW. AMP-Activated protein kinase control of fat metabolism in skeletal muscle. Acta Physiol (Oxf) 2009;196: 147-154
16. Lindholm CR, Ertel RL, Bauwens JD, Schmuck EG, Mulligan JD, Saupe KW. A high-fat diet decreases AMPK activity in multiple tissues in the absence of hyperglycemia or systemic inflammation in rats. J Physiol Biochem 2013;69: 165-175
17. Martin TL, Alquier T, Asakura K, Furukawa N, Preitner F, Kahn BB. Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle. J Biol Chem 2006;281: 18933-18941
18. Hardie DG. AMPK: A key regulator of energy balance in the single cell and the whole organism. Int J Obes 2008;32(Suppl. 4): S7-S12
19. Jackson TR, Kearns BG, Theibert AB. Cytohesins and centaurins: Mediators of PI 3-kinase-regulated Arf signaling. Trends Biochem Sci 2000;25: 489-495
20. Liu X, Hu Y, Hao C, Rempel SA, Ye K. PIKE-A is a proto-oncogene promoting cell growth, transformation and invasion. Oncogene 2007;26: 4918-4927
21. Ahn JY, Hu Y, Kroll TG, Allard P, Ye K. PIKE-A is amplified in human cancers and prevents apoptosis by up-regulating Akt. Proc Natl Acad Sci U S A 2004;101: 6993-6998
22. Chan CB, Liu X, He K, et al. The association of phosphoinositide 3-kinase enhancer A with hepatic insulin receptor enhances its kinase activity. EMBO Rep 2011;12: 847-854
23. Chan CB, Liu X, Jung DY, et al. Deficiency of phosphoinositide 3-kinase enhancer protects mice from diet-induced obesity and insulin resistance. Diabetes 2010;59: 883-893
24. Chan CB, Liu X, Ensslin MA, et al. PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. EMBO J 2010;29: 956-968
25. Burattini S, Ferri P, Battistelli M, Curci R, Luchetti F, Falcieri E. C2C12 murine myoblasts as a model of skeletal muscle development: Morpho-functional characterization. Eur J Histochem 2004;48: 223-233
26. Magnoni LJ, Vraskou Y, Palstra AP, Planas JV. AMP-Activated protein kinase plays an important evolutionary conserved role in the regulation of glucose metabolism in fish skeletal muscle cells. PLoS One 2012;7: E31219
27. Noda K, Nakajima S, Godo S, et al. Rho-kinase inhibition ameliorates metabolic disorders through activation of AMPK pathway in mice. PLoS One 2014;9: E110446
28. Furda A, Santos JH, Meyer JN, Van Houten B. Quantitative PCR-based measurement of nuclear and mitochondrial DNA damage and repair in mammalian cells. Methods Mol Biol 2014;1105: 419-437
29. Jing E, O'Neill BT, Rardin MJ, et al. Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation. Diabetes 2013;62: 3404-3417
30. Wueest S, Mueller R, Blüher M, et al. Fas (CD95) expression in myeloid cells promotes obesity-induced muscle insulin resistance. EMBO Mol Med 2014;6: 43-56
31. Chan CB, Liu X, Pradoldej S, et al. Phosphoinositide 3-kinase enhancer regulates neuronal dendritogenesis and survival in neocortex. J Neurosci 2011;31: 8083-8092
32. Winder WW, Hardie DG. Inactivation of acetyl-CoA carboxylase and activation of AMP-Activated protein kinase in muscle during exercise. Am J Physiol 1996;270: E299-E304
33. Cool B, Zinker B, Chiou W, et al. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab 2006;3: 403-416
34. Zachariah Tom R, Garcia-Roves PM, Sjögren RJ, et al. Effects of AMPK activation on insulin sensitivity and metabolism in leptin-deficient ob/ob mice. Diabetes 2014;63: 1560-1571
35. Kim KA, Gu W, Lee IA, Joh EH, Kim DH. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One 2012;7: E47713
36. Araújo EP, De Souza CT, Ueno M, et al. Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes. Endocrinology 2007;148: 5991-5997
37. Geng Y, Hansson GK, Holme E. Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res 1992;71: 1268-1276
38. Jia L, Kelsey SM, Grahn MF, Jiang XR, Newland AC. Increased activity and sensitivity of mitochondrial respiratory enzymes to tumor necrosis factor alphamediated inhibition is associated with increased cytotoxicity in drug-resistant leukemic cell lines. Blood 1996;87: 2401-2410
39. Lacerda L, McCarthy J, Mungly SF, et al. TNFα protects cardiac mitochondria independently of its cell surface receptors. Basic Res Cardiol 2010;105: 751-762
40. He K, Jang SW, Joshi J, Yoo MH, Ye K. Akt-phosphorylated PIKE-A inhibits UNC5B-induced apoptosis in cancer cell lines in a p53-dependent manner. Mol Biol Cell 2011;22: 1943-1954
41. Tse MC, Liu X, Yang S, Ye K, Chan CB. Fyn regulates adipogenesis by promoting PIKE-A/STAT5a interaction. Mol Cell Biol 2013;33: 1797-1808
42. Zhang S, Qi Q, Chan CB, et al. Fyn-phosphorylated PIKE-A binds and inhibits AMPK signaling, blocking its tumor suppressive activity. Cell Death Differ 2016;23: 52-63
43. Hoehn KL, Turner N, Swarbrick MM, et al. Acute or chronic upregulation of mitochondrial fatty acid oxidation has no net effect on whole-body energy expenditure or adiposity. Cell Metab 2010;11: 70-76
44. Wang J, Vanegas SM, Du X, et al. Caloric restriction favorably impacts metabolic and immune/inflammatory profiles in obese mice but curcumin/piperine consumption adds no further benefit. Nutr Metab (Lond) 2013;10: 29
45. Bruce CR, Dyck DJ. Cytokine regulation of skeletal muscle fatty acid metabolism: Effect of interleukin-6 and tumor necrosis factor-Alpha. Am J Physiol Endocrinol Metab 2004;287: E616-E621
46. Sakurai Y, Zhang XU, Wolfe RR. Short-Term effects of tumor necrosis factor on energy and substrate metabolism in dogs. J Clin Invest 1993;91: 2437-2445
47. Jäger S, Handschin C, St-Pierre J, Spiegelman BM. AMP-Activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci U S A 2007;104: 12017-12022
48. Lantier L, Fentz J, Mounier R, et al. AMPK controls exercise endurance, mitochondrial oxidative capacity, and skeletal muscle integrity. FASEB J 2014;28: 3211-3224